Synthesis of novel phenyl azo chalcone derivatives for antitubercular, antiinflammatory and antioxidant activity

Der Pharma Chemica

Volumn 7, Issue 1, 2015, Pages 77-83

  Rohini, R M ^a   Devi, Kalpana ^a   Devi, Simi ^a  

^a AL AMEEN COLLEGE OF PHARMACY   (India)

Author keywords

Anti inflammatory; Antioxidant activity; Antitubercular; Phenyl azochalcone

Indexed keywords

1 [4 (4 AMINO 2 METHYLPHENYLAZO)PHENYL] 3 (3,4,5 TRIMETHOXYPHENYL)PROPENONE; 1 [4 (4 AMINO 2 METHYLPHENYLAZO)PHENYL] 3 (4 HYDROXYPHENYL)PROPENONE; 1 [4 (4 AMINO 2 METHYLPHENYLAZO)PHENYL] 3 (4 METHOXYPHENYL)PROPENONE; 1 [4 (4 AMINO 2 METHYLPHENYLAZO)PHENYL] 3 (4 NITROPHENYL)PROPENONE; 1 [4 (4 AMINO 2 METHYLPHENYLAZO)PHENYL] 3 PARA TOLYLPROPENONE; 1 [4 (4 AMINO 3 METHOXYPHENYLAZO)PHENYL] 3 (3,4,5 TRIMETHOXYPHENYL)PROPENONE; 1 [4 (4 AMINO 3 METHOXYPHENYLAZO)PHENYL] 3 (4 HYDROXYPHENYL)PROPENONE; 1 [4 (4 AMINO 3 METHOXYPHENYLAZO)PHENYL] 3 (4 METHOXYPHENYL)PROPENONE; 1 [4 (4 AMINO 3 METHOXYPHENYLAZO)PHENYL] 3 (4 NITROPHENYL)PROPENONE; 1 [4 (4 AMINOPHENYLAZO)PHENYL] 3 (3,4,5 TRIMETHOXYPHENYL)PROPENONE; 1 [4 (4 AMINOPHENYLAZO)PHENYL] 3 (4 HYDROXYPHENYL)PROPENONE; 1 [4 (4 AMINOPHENYLAZO)PHENYL] 3 (4 METHOXYPHENYL)PROPENONE; 1 [4 (4 AMINOPHENYLAZO)PHENYL] 3 (4 NITROPHENYL)PROPENONE; 1 [4 (4 AMINOPHENYLAZO)PHENYL] 3 PARA TOLYLPROPENONE; 1 [4 (4 HYDROXYNAPHTHALEN 2 YLAZO)PHENYL] 3 (3,4,5 TRIMETHOXYPHENYL)PROPENONE; 1 [4 (4 HYDROXYNAPHTHALEN 2 YLAZO)PHENYL] 3 (4 HYDROXYPHENYL)PROPENONE; 1 [4 (4 HYDROXYNAPHTHALEN 2 YLAZO)PHENYL] 3 (4 METHOXYPHENYL)PROPENONE; 1 [4 (4 HYDROXYNAPHTHALEN 2 YLAZO)PHENYL] 3 (4 NITROPHENYL)PROPENONE; 1 [4 (4 HYDROXYNAPHTHALEN 2 YLAZO)PHENYL] 3 PARA TOLYLPROPENONE; 3 PHENYL 1 (4 PHENYLAZOPHENYL)PROPENONE DERIVATIVE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ASCORBIC ACID; CHALCONE DERIVATIVE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL ANALYSIS; CLAISEN CONDENSATION; CONTROLLED STUDY; DIAZOTIZATION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 84924092412     PISSN: None     EISSN: 0975413X     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Part-IV, Studies on chalcone. http://shodhganga.inflibnet.ac.in/bitstream/10603/2162/11/11_part%204.pdf.
2. http://www.who.int/tdr/diseases/tb/default.htm.
3. K.B.Raut, D.H.Wendor. J Org Chem., 1960, 25, 2126.
4. http://en.wikipedia.org/wiki/Non-steroidal_anti-inflammatory_drug.
5. http://en.wikipedia.org/wiki/Antioxidant.
6. S.K. Awasthi, N. Mishra, B. Kumar, M. Sharma, A. Bhattacharya et al. Med Chem Res., 2009, 18, 407-20.
7. K. Ilango, P. Valentina, G. Saluja. Res J Pharm Bio Chem Sci., 2010, 1, 354-59.
8. P.M. Shivakumar, G.S.M. Babu, D. Mukesh, Chem&Pharm Bulleti., 2005, 55, 44-49.
9. A. Detsi, M. Majdalani, A. Christos, K. Dimitra, L. Hadjipavlou, P. Kefalas. Bio Org&Med Chem., 2009, 17(23), 8073-8085.
10. S.Vogel, M. Barbic, G. Jürgenliemk J. Heilmann, Eur J of Med Chem., 2010, 45(6), 2206-2213.
11. A.F.W.Warder, Int J Chem Sci App., 2012, 3, 356-65.
12. S.G.Franzblau, R.S.Witzig, J.C.McLaughlin, P.Torres, G.Madico, A.Hernandez, M.T.Degnan, M.B.Cook, V.K.Quenzer, R.M.Ferguson, R.H.Gilman, J.Clin.Microbiol., 1998, 36, 362-366.
13. Z. Nowakowska, Eur J Chem., 2007, 42, 125-137.
14. L.L.Mensor, F.S.Menzes, G.G.Leitao, A.S.Reis, T.C.Dosantos, C.S.Coube, Phytother Res., 2001, 15, 127-13.